Invention Grant
- Patent Title: Tri-cyclic pyrazolopyridine kinase inhibitors
- Patent Title (中): 三环吡唑并吡啶激酶抑制剂
-
Application No.: US12670989Application Date: 2010-01-27
-
Publication No.: US08569337B2Publication Date: 2013-10-29
- Inventor: Juan-Miguel Jimenez , John Studley , Ronald Knegtel , Luca Settimo , Christopher John Davis , Damien Fraysse , Philip N. Collier , Guy Brenchley , Dean Boyall , Andrew Miller , Heather Twin , Stephen Young
- Applicant: Juan-Miguel Jimenez , John Studley , Ronald Knegtel , Luca Settimo , Christopher John Davis , Damien Fraysse , Philip N. Collier , Guy Brenchley , Dean Boyall , Andrew Miller , Heather Twin , Stephen Young
- Applicant Address: US MA Cambridge
- Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee Address: US MA Cambridge
- Agent Min Lin
- Main IPC: A61K31/437
- IPC: A61K31/437 ; C07D471/04
Abstract:
The present invention relates to compounds of tri-cyclic pyrazolopyridine useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions containing such compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.
Public/Granted literature
- US20120136000A1 TRI-CYCLIC PYRAZOLOPYRIDINE KINASE INHIBITORS Public/Granted day:2012-05-31
Information query
IPC分类:
